TY - JOUR
T1 - 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
AU - Knuuti, Juhani
AU - Wijns, William
AU - Achenbach, Stephan
AU - Agewall, Stefan
AU - Barbato, Emanuele
AU - Bax, Jeroen J.
AU - Capodanno, Davide
AU - Cuisset, Thomas
AU - Deaton, Christi
AU - Dickstein, Kenneth
AU - Edvardsen, Thor
AU - Escaned, Javier
AU - Funck-Brentano, Christian
AU - Gersh, Bernard J.
AU - Gilard, Martine
AU - Hasdai, David
AU - Hatala, Robert
AU - Mahfoud, Felix
AU - Masip, Josep
AU - Muneretto, Claudio
AU - Prescott, Eva
AU - Saraste, Antti
AU - Storey, Robert F.
AU - Svitil, Pavel
AU - Valgimigli, Marco
AU - Windecker, Stephan
AU - Aboyans, Victor
AU - Baigent, Colin
AU - Collet, Jean Philippe
AU - Dean, Veronica
AU - Delgado, Victoria
AU - Fitzsimons, Donna
AU - Gale, Christopher P.
AU - Grobbee, Diederick E.
AU - Halvorsen, Sigrun
AU - Hindricks, Gerhard
AU - Iung, Bernard
AU - Jüni, Peter
AU - Katus, Hugo A.
AU - Landmesser, Ulf
AU - Leclercq, Christophe
AU - Lettino, Maddalena
AU - Lewis, Basil S.
AU - Merkely, Bela
AU - Mueller, Christian
AU - Petersen, Steffen
AU - Petronio, Anna Sonia
AU - Richter, Dimitrios J.
AU - Roffi, Marco
AU - Shlyakhto, Evgeny
AU - Task Force
AU - European Society of Cardiology (ESC)
AU - ESC Committee for Practice Guidelines (CPG)
PY - 2020/1/14
Y1 - 2020/1/14
N2 - Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve disease stabilization or regression. The disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event caused by plaque rupture or erosion. However, the disease is chronic, most often progressive, and hence serious, even in clinically apparently silent periods. The dynamic nature of the CAD process results in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). The Guidelines presented here refer to the management of patients with CCS. The natural history of CCS is illustrated in Figure 1.
AB - Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve disease stabilization or regression. The disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event caused by plaque rupture or erosion. However, the disease is chronic, most often progressive, and hence serious, even in clinically apparently silent periods. The dynamic nature of the CAD process results in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). The Guidelines presented here refer to the management of patients with CCS. The natural history of CCS is illustrated in Figure 1.
KW - Angina pectoris
KW - Anti-ischaemic drugs
KW - Antithrombotic therapy
KW - Chronic coronary syndromes
KW - Coronary artery disease
KW - Diagnostic testing
KW - Guidelines
KW - Imaging
KW - Lifestyle modifications
KW - Lipid-lowering drugs
KW - Microvascular angina
KW - Myocardial ischaemia
KW - Myocardial revascularization
KW - Risk assessment
KW - Screening
KW - Vasospastic angina
U2 - 10.1093/eurheartj/ehz425
DO - 10.1093/eurheartj/ehz425
M3 - Review article
C2 - 31504439
AN - SCOPUS:85077946639
VL - 41
SP - 407
EP - 477
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 3
ER -